Literature DB >> 26231975

Reactive angioendotheliomatosis as a presenting cutaneous manifestation of Hughes syndrome.

B Nikam1, S Shah2, M Kale2, V Jamale2.   

Abstract

BACKGROUND: Antiphospholipid antibody syndrome is an autoimmune disorder associated with pregnancy complications, venous and/or arterial thrombosis and the presence of antiphospholipid antibodies. This syndrome is known to present with various cutaneous features, but association with reactive angioendotheliomatosis has been described rarely in the literature.
RESULTS: A woman in her thirties with a past history of three consecutive abortions developed purpuric, ulcerative plaque over the plantar aspect of the foot. Her biopsy showed marked expansion of dermal vasculature due to intravascular cellular proliferation suggestive of reactive angioendotheliomatosis. The intravascular cells stained positive for CD31. Her blood investigations showed positive lupus anticoagulant, antiphospholipid antibodies and anticardiolipin antibodies, leading to a diagnosis of antiphospholipid syndrome also known as Hughes syndrome.
CONCLUSION: We suggest that a hypercoagulable state caused the formation of intravascular thrombi leading to reactive angioendotheliomatosis. We report a case of Hughes syndrome with reactive angioendotheliomatosis as the first clinical cutaneous manifestation and treated satisfactorily with anticoagulants and immunomodulators.
© The Author(s) 2015.

Entities:  

Keywords:  Antiphospholipid syndrome; reactive angioendotheliomatosis

Mesh:

Substances:

Year:  2015        PMID: 26231975     DOI: 10.1177/0961203315598245

Source DB:  PubMed          Journal:  Lupus        ISSN: 0961-2033            Impact factor:   2.911


  1 in total

1.  Glomeruloid reactive angioendotheliomatosis in a woman with systemic lupus erythematosus and antiphospholipid syndrome mimicking reticular erythematous mucinosis.

Authors:  Caterina Ferreli; Laura Atzori; Franco Rongioletti
Journal:  JAAD Case Rep       Date:  2020-12-17
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.